Merck & Co (MRK)
$85.98 2.58 (2.91%)
19:59 EST MRK Stock Quote Delayed 15 Minutes
Previous Close $85.98
Market Cap 231.31B
PE Ratio 148.24
Volume (Avg. Vol.) 14.27M
Day's Range 85.58 - 88.83
52-Week Range 72.05 - 92.64
Dividend & Yield 1.92 (2.23%)
MRK Stock Predictions, Articles, and Merck & Co News
- From InvestorPlace
- From the Web
FDA approval of Vascepa in use for cardiovascular events just widened Amarin’s revenue potential. Amarin stock should have a banner 2020.
Though the market is at all-time highs, not every stock can say the same. These three stocks to buy should reach new peaks in 2020.
Here are three of the best healthcare stocks to buy, as the sector is flashing a 'buy-the-dip' setup to kick off the New Year.
In this volatile market, blue-chip stocks will get you through. Here are five of the bluest stocks to buy today.
Thursday's 3 big stock charts highlight 3 recent movers that could rally if broad market optimism continues.
Some of today's malaise can be attributed to Alphabet (NASDAQ:GOOGL,GOOG), which declined following a disappointing earnings report issued yesterday after the market closed. The internet search giant reported earnings of $10.12 a share on revenue of $40.50 billion while analysts expected earnings of $12.42 on revenue of $40.32 billion.
With FDA Breakthrough Therapy designations and robust drug pipelines, these biotech companies are all stocks to buy for 2020.
A divided Federal Reserve is a new issue for investors to consider. Read more about what happened in the Dow Jones today.
The stock charts of MSFT, FB and MRK have earned a closer technical look as the new trading week kicks off.
Bristol-Myers Squibb stock touched a multi-year low last month. But the BMY stock price is cheap enough now to take on real risks.
Here we looked for five of the Street’s highest-rated Dow Jones stocks right now. As you will see all five of these stocks show a firm ‘Strong Buy’ Street consensus. That's based on all the ratings received by each stock over the last three months.
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
Longstanding cycles in CVS Health and Merck are at risk of changing and offering profits to spread traders buying CVS stock and shorting MRK.
Options trading was buzzing in Bed Bath & Beyond, CVS, and Merck on Thursday. Here are the metrics that matter moving forward.
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
Navellier RatingsPowered by Portfolio Grader